Awareness, Care & Treatment In Obesity Management (ACTION-France)

Novo Nordisk

Status: Completed

Conditions: Obesity

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT05690789

U1111-1267-0332 (Other Identifier)

DAS-009

Details and patient eligibility

About

ACTION France is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Enrollment: 1,688 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

People Living with Obesity

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, aged above or equal to 18 years at the time of signing informed consent Lives in France
3. Current BMI based on self-reported height and weight of at least 30 kg/m^2

Health Care Professionals

1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
2. Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
3. Physician with a license to practice
4. Specialty is not surgeon (including bariatric or plastic surgeon)
5. Practices in France
6. In clinical practice greater than or equal to 2 years
7. Spends at least 70 percent time in direct patient care
8. Has seen at least 100 patients in past month
9. Has seen at least 10 patients in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 kg/m^2 with or without comorbidities.

Employers

1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
2. Age 18 years old or older
3. works in France
4. Company offers health insurance benefits
5. Responsible for making or influencing decisions about employee benefits plan or health and wellness programs
6. works in a company that has at least 20 employees
7. not affiliated with pharma, MR or advertising firms

Exclusion criteria

People Living with obesity

1. Previous participation in this study. Participation is defined as having given online consent in this study
2. Currently pregnant
3. Participates in intense fitness or body building programs
4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Health Care Providers

1. Previous participation in this study. Participation is defined as having given informed consent in this study.
2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Employers

1. Previous participation in this study. Participation is defined as having given informed consent in this study.
2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Trial design

1,688 participants in 3 patient groups

People / Person Living with Obesity (PLwO)

Description:

From online, general population consumer panels

Treatment:

Other: No treatment given

Health Care Professionals (HCPs)

Description:

HCPs treating people who have obesity

Treatment:

Other: No treatment given

Employers

Description:

Single-selection response from defined list

Treatment:

Other: No treatment given